RSRazieh Shahnazari

Razieh Shahnazari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Razieh Shahnazari has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Artificial Intelligence in Soft Tissue Tumor Evaluation in View of Radiological Images Evaluation: Systematic Review and Meta-Analysis

    by Masih Rikhtehgar, Razieh Shahnazari, Afshin Shiri, Mohamad Reza Ayoubpour, Samaneh Azimi Souteh, Narges Badragheh

    Introduction: In the field of oncological radiography imaging, artificial intelligence (AI) plays pivotal role, aiding both diagnosis and treatment. While computer-aided diagnosis has been employed in cancer imaging previously, it has shown limited clinical value; however, AI-based models are now routinely part of body organ imaging and are clinically used in many circumstances. The present study aimed to evaluate the diagnostic accuracy of AI in soft tissue tumor evaluation in view of radiological images evaluation. Methodology: The present systematic review and meta-analysis included seven cohort studies of international databases, PubMed, Scopus, Web of Science, and Embase, from January 1, 2015, to May 10, 2025, using keywords aligned with the study objective. The statistical analysis was performed with Stata/MP.v17 as fixed effect models. Results: The accuracy of AI in soft tissue tumor assessment based on radiological images was 82% (ES = 0.82; 95% CI 0.68-0.96). The sensitivity and specificity of AI in soft tissue tumor assessment based on radiological images were 74%, and 88%, respectively. Conclusion: AI tools related to imaging with high accuracy, sensitivity, and acceptable specificity can take positive steps toward helping in the diagnosis of soft tissue tumors.

  • Optimizing Venographic Referrals in Pelvic Congestion Syndrome

    by Mohammad Masih Mansouri‐Tehrani, Razieh Shahnazari, Hamed Iraji, Mohammad Mersad Mansouri Tehrani, Moein Ghasemi

    Objectives: Pelvic congestion syndrome (PCS) is a prevalent but underdiagnosed cause of chronic pelvic pain. Venography remains the diagnostic reference, yet its invasiveness limits routine use. This study evaluated standardized duplex ultrasound and developed a scoring system to guide selective, evidence‐based venographic referral. Methods: In this prospective diagnostic‐accuracy study, 60 women with chronic pelvic pain underwent standardized transabdominal and transvaginal duplex ultrasound, and 40 subsequently underwent selective venography as the reference standard. Ultrasound parameters included venous diameter, evoked caudal flow duration, flow direction, velocity, bilaterality, and myometrial plexus enlargement. Penalized logistic regression with bootstrap‐nested cross‐validation identified independent predictors of venography‐confirmed PCS. Coefficients were converted into a point‐score to classify patients into rule‐out, indeterminate, and rule‐in bands. Diagnostic performance, calibration, and decision‐curve analyses were used to evaluate discrimination and clinical utility across probability thresholds. Results: Venography confirmed PCS in 26 of 40 participants (65%). A 6‐mm diameter threshold provided optimal diagnostic balance (sensitivity 92.3%, specificity 64.3%). The penalized model retained diameter, reflux ≥1.0 second, low velocity ≤3 cm/second, Valsalva‐evoked caudal flow, myometrial plexus enlargement, and bilaterality, achieving an optimism‐corrected AUC of 0.861. The derived score stratified patients into rule‐out, indeterminate, and rule‐in groups with high predictive accuracy (positive predictive value 93.3%, negative predictive value 91.7%). Decision‐curve analysis showed higher net benefit than treat‐all or treat‐none strategies. Conclusion: Standardized duplex ultrasound integrating morphologic and hemodynamic parameters accurately identified venographic PCS and enabled selective triage. The validated score supports ultrasound as an effective, noninvasive first‐line tool to optimize venography and guide patient‐centered management.


  • Open Access

    The Tale of a Giant Calcaneal Spur Measuring 31 mm: A Rare Case Report

    by Razieh Shahnazari, Marlena Jabra, Sina Karaji, Niloofar Alimohamadi, Shahriar Shirzadi

    Introduction: This study presents a unique case report of a 31 mm calcaneal spur, shedding light on the complexities of heel spur formation and its consequences. The connection between spur length and pain intensity remains uncertain, while factors such as obesity, biomechanical foot disorder, combined tarsal coalition, and loading patterns are implicated in their development. Case Presentation: A 38-year-old male with chronic plantar fasciitis and persistent heel discomfort presented with a congenitally shorter affected foot. Following initial medical attention for heel pain and an unidentified injection providing temporary relief, his symptoms worsened significantly over three months, reaching a distressing level of 8/10 on the pain scale. Morning and post-rest exacerbations were noticeably mitigated by activity. An X-ray revealed a 31 × 17 mm heel spur at the plantar calcaneal tuberosity with dysplastic rounded mortise and calcaneus. MRI showed evidence of extraarticular non-osseous talocalcaneal coalitions with degenerative changes in the angle of Gissane. It is possible that the patient’s problems are due to the initial coalition and secondary heel spur and plantar fasciitis. Conclusion: This rare case of a 31 mm calcaneal spur emphasizes the diagnostic value of advanced imaging in complex heel pain. While spur size alone may not predict symptoms, associated biomechanical and structural anomalies complicate management. Non-surgical treatments remain primary, but surgical options may be necessary for resistant cases. Further studies are needed to guide treatment strategies for unusually large spurs.

  • Open Access

    Psammomatoid ossifying fibroma in the frontal sinus: An intriguing clinical encounter—A detailed case report

    by Pegah Babaheidarian, Parisa Mokhles, Saleh Mohebbi, Razieh Shahnazari, Nasser Karimi, Donya Ghazinia, Sina Karaji, Shahriar Shirzadi

    Background: Psammomatoid ossifying fibroma (POF) is a rare craniofacial neoplasm, primarily affecting the maxillofacial region, and typically observed in adolescents and young adults. This case report presents a unique occurrence of POF in a 50‐year‐old male, defying the conventional age range and exhibiting an unusual anatomical location within the frontal sinus.Case: A 50‐year‐old male with a prior history of cecal adenocarcinoma and colectomy presented with left eye proptosis and new‐onset headaches. Imaging revealed a well‐defined calcified mass in the left frontal sinus, leading to a diagnosis of POF. Open surgical resection was performed to remove the tumor, and histopathological evaluation confirmed its diagnosis as psammomatoid ossifying fibroma. The patient exhibited no postoperative complications or signs of recurrence.Conclusion: This case underscores the diverse clinical presentations and diagnostic challenges associated with POF, emphasizing the importance of accurate diagnosis and multidisciplinary collaboration. Further research is needed to explore the genetic underpinnings and optimal management strategies for this intriguing condition.


  • Open Access

    Endometrial cancer arising from adenomyosis with unusual manifestation: A case report

    by Razieh Shahnazari, Shahriar Shirzadi, Sina Karaji, Parisa Mokhles, Mohamad Javad Ghafouri Far, Salome Maghsudlu

    Key Clinical Message: Endometrial Carcinoma Arising from Adenomyosis (EC‐AIA) is an unusual condition, primarily occurring in postmenopausal women. We present a rare case of a 34‐year‐old woman with EC‐AIA, highlighting the diagnostic challenges in distinguishing this malignancy from adenomyosis preoperatively. Conventional imaging methods exhibited limitations, necessitating post‐surgery confirmation through comprehensive examinations. The case emphasizes the need for a multidisciplinary approach for accurate diagnosis and timely management in such uncommon gynecological conditions.


  • Open Access

    Extraskeletal mesenchymal chondrosarcoma arising from soft tissues: A rare case report

    by Razieh Shahnazari, Fatemeh Montazer, Shahriar Shirzadi, Sina Karaji

    Background: Chondrosarcomas are an exceedingly rare form of cancer, impacting only a few individuals per million. Among chondrosarcomas, a small fraction belongs to the mesenchymal sub‐type. Furthermore, only one‐third of mesenchymal chondrosarcomas manifest in extraskeletal locations.Case: A 38‐year‐old woman was referred by a midwife after experiencing pain in the right upper quadrant of her right breast for 2 months. The mass had been palpable for 1 week before the initial assessment. According to radiological evaluations, the tumor is outside breast tissue and not connected to the bones. Hence, a biopsy of the mass is done. The biphasic morphology of the tumor during pathological evaluation, in addition to immunohistochemistry testing, confirms the diagnosis of extraskeletal mesenchymal chondrosarcoma (EMCS). Finally, the mass was surgically removed, and 6 months of chemotherapy were administered to the patient.Conclusion: Given the tumor's rarity and the lack of established guidelines, diagnosing EMCS can be challenging and prone to errors. As such, meticulous sampling, along with precise pathological and imaging investigations, is imperative to accurately establish the diagnosis of these tumors.


  • Open Access

    CT severity score in COVID-19 patients, assessment of performance in triage and outcome prediction: a comparative study of different methods

    by Alireza Almasi Nokiani, Razieh Shahnazari, Mohammad Amin Abbasi, Farshad Divsalar, Marzieh Bayazidi, Azadeh Sadatnaseri

    Background: Lung involvement in COVID-19 can be quantified by chest CT scan with some triage and prognostication value. Optimizing initial triage of patients could help decrease adverse health impacts of the disease through better clinical management. At least 6 CT severity score (CTSS) systems have been proposed. We aimed to evaluate triage and prognostication performance of seven different CTSSs, including one proposed by ourselves, in hospitalized COVID-19 patients diagnosed by positive polymerase chain reaction (PCR). Results: After exclusion of 14 heart failure and significant preexisting pulmonary disease patients, 96 COVID-19, PCR-positive patients were included into our retrospective study, admitted from February 20, 2020, to July 22. Their mean age was 63.6 ± 17.4 years (range 21–88, median 67). Fifty-seven (59.4%) were men, and 39 (40.6%) were women. All CTSSs showed good interrater reliability as calculated intraclass correlation coefficients (ICCs) between two radiologists were 0.764–0.837. Those CTSSs with more numerous segmentations showed the best ICCs. As judged by area under curve (AUC) for each receiver operator characteristic (ROC) curve, only three CTSSs showed acceptable AUCs (AUC = 0.7) for triage of severe/critical patients. All CTSSs showed acceptable AUCs for prognostication (AUCs = 0.76–0.79). Calculated AUCs for different CTSSs were not significantly different for triage and for prediction of severe/critical disease, but some difference was shown for prediction of critical disease. Conclusions: Men are probably affected more frequently than women by COVID-19. Quantification of lung disease in COVID-19 is a readily available and easy tool to be used in triage and prognostication, but we do not advocate its use in heart failure or chronic respiratory disease patients. The scoring systems with more numerous segmentations are recommended if any future imaging for comparison is contemplated. CTSS performance in triage was much lower than earlier reports, and only three CTSSs showed acceptable AUCs in this regard. CTSS performed better for prognostic purposes than for triage as all 7 CTSSs showed acceptable AUCs in both types of prognostic ROC curves. There is not much difference among performance of different CTSSs.